Clinical Trial Update: Bioavailability of AZD0284 and IV Microtracer Study [Phase 1]

View source ↗

Summary

Phase 1 bioavailability study of AZD0284 with an IV microtracer has completed in patients with plaque psoriasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• AZD0284

Snippet

Sponsor: AstraZeneca | Conditions: Plaque Psoriasis Vulgaris | Phase 1 | Status: COMPLETED